LAB
Standard BioTools Inc.
0.91
3 x 0.91
6 x 1.13
bid
ask
+
0.05
5.50%
10:04 AM
timesize
| Ytd | -28.55% | |
| 1y | -33.25% |
0.85
day range
0.92
0.70
52 week range
1.72
| Open | 0.85 | Prev Close | 0.87 | Low | 0.85 | High | 0.92 | Mkt Cap | 358.58M |
| Vol | 214.89K | Avg Vol | 3.83M | EPS | -0.13 | P/E | N/A | Forward P/E | -8.50 |
| Beta | 1.57 | Short Ratio | 5.30 | Inst. Own | 73.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 0.95 | 200-d Avg | 1.18 | 1yr Est | 3.08 |
| Income Statement | |||
| Total Revenue | 21.15M | ||
| Revenues (USD) | 21.15M | ||
| Cost of Revenue | 9.84M | ||
| Gross Profit | 11.31M | ||
| Operating Expenses | 23.80M | ||
| Research and Development Expense | 2.12M | ||
| Selling, General and Administrative Expense | 18.61M | ||
| Operating Income | -12.50M | ||
| Income Tax Expense | 11.00K | ||
| Net Income | 127.07M | ||
| Net Income Common Stock | 127.07M | ||
| Net Income Common Stock (USD) | 127.07M | ||
| Consolidated Income | 127.07M | ||
| Net Income from Discontinued Operations | -141.69M | ||
| Earnings per Basic Share | 0.33 | ||
| Earnings per Basic Share (USD) | 0.33 | ||
| Earnings per Diluted Share | 0.33 | ||
| Earning Before Interest & Taxes (EBIT) | 127.08M | ||
| Earning Before Interest & Taxes (USD) | 127.08M | ||
| Weighted Average Shares | 388.20M | ||
| Weighted Average Shares Diluted | 388.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 265.77M | ||
| Cash and Equivalents (USD) | 265.77M | ||
| Investments | 260.76M | ||
| Investments Current | 189.40M | ||
| Investments Non-Current | 71.36M | ||
| Trade and Non-Trade Receivables | 41.64M | ||
| Current Assets | 521.45M | ||
| Property, Plant & Equipment Net | 42.65M | ||
| Total Assets | 639.11M | ||
| Debt Current | 5.54M | ||
| Total Debt | 29.49M | ||
| Current Liabilities | 42.20M | ||
| Debt Non-Current | 23.95M | ||
| Total Liabilities | 77.99M | ||
| Accumulated Retained Earnings (Deficit) | -1.13B | ||
| Accumulated Other Comprehensive Income | -511.00K | ||
| Shareholders Equity | 561.12M | ||
| Shareholders Equity (USD) | 561.12M | ||
| Assets Non-Current | 117.66M | ||
| Total Debt (USD) | 29.49M | ||
| Deferred Revenue | 19.54M | ||
| Inventory | 18.59M | ||
| Liabilities Non-Current | 35.79M | ||
| Trade and Non-Trade Payables | 8.01M | ||
| Tax Assets | 270.00K | ||
| Tax Liabilities | 823.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.76M | ||
| Net Cash Flow from Financing | -40.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 144.57M | ||
| Capital Expenditure | -570.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 363.22M | ||
| Issuance (Purchase) of Equity Shares | 78.00K | ||
| Net Cash Flow from Investing | 191.09M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -171.56M | ||
| Net Cash Flow from Operations | -46.60M | ||
| Effect of Exchange Rate Changes on Cash | 115.00K | ||
| Share Based Compensation | 8.82M | ||